New hope for PAH patients: daily inhaler aims to boost stamina
NCT ID NCT07481981
Summary
This study aims to see if a new once-daily inhaled powder can help adults with pulmonary arterial hypertension (PAH) walk farther and feel better. It will compare the new treatment to a placebo (inactive powder) over 24 weeks in about 344 people who are already on stable PAH medications. The main goal is to measure improvement in how far participants can walk in six minutes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.